FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386019076> ?p ?o ?g. }

• W4386019076 endingPage "6" @default.
• W4386019076 startingPage "1" @default.
• W4386019076 abstract "Because of lacking of head-to-head comparison between venetoclax and IDH1/IDH2 inhibitors (ivosidenib/enasidenib) for newly diagnosed unfit patients with acute myeloid leukemia (AML), the optimal option for these patients still remains undefined. We searched relevant published reports. Three RCTs with 180 IDH1 mutant and 165 IDH2 mutant patients were identified. Indirect comparison of OS using fixed effects network meta-analysis (NMA) models indicated venetoclax plus azacitidine (Ven-Aza) significantly improved survival than enasidenib plus azacitidine (Ena-Aza) (HR:0.30, p = 0.005) for those newly diagnosed patients with AML and IDH2 Mutation. And, for those IDH2 mutation patients, Ven-Aza also had the highest probability of 98.3% (OS analysis) and 84.0% (CR/CRi analysis) to be the best intervention among these first-line treatment regimens (Ven-Aza, Ena-Aza and Aza). And, there was a favorable trend towards Ven-Aza in survival analysis (HR:0.69, p = 0.42), when compared to ivosidenib plus azacitidine (Ivo-Aza) for those newly diagnosed patients with AML and IDH1 Mutation. For those IDH1 Mutation, venetoclax plus azacitidine (Ven-Aza) had the highest probability of 65.8% (OS analysis) and 73.0% (CR/CRi analysis) to be the best intervention among these first-line treatment regimens (Ven-Aza, ivosidenib plus azacitidine (Ivo-Aza) and azacitidine (Aza)). In conclusion, venetoclax plus azacitidine could be a good option for unfit newly diagnosed patients with acute myeloid leukemia and IDH1/2 mutation. Considering our limits (only trial data-based network meta-analysis et al.), future trials directly comparing these regimens are warranted." @default.
• W4386019076 created "2023-08-22" @default.
• W4386019076 creator A5004638853 @default.
• W4386019076 creator A5040931931 @default.
• W4386019076 creator A5057659279 @default.
• W4386019076 creator A5059618793 @default.
• W4386019076 creator A5086006586 @default.
• W4386019076 creator A5088738935 @default.
• W4386019076 date "2023-08-20" @default.
• W4386019076 modified "2023-10-09" @default.
• W4386019076 title "Comparison of venetoclax and ivosidenib/enasidenib for unfit newly diagnosed patients with acute myeloid leukemia and <i>IDH1/2</i> mutation: a network meta-analysis" @default.
• W4386019076 cites W1600365609 @default.
• W4386019076 cites W1979521298 @default.
• W4386019076 cites W1990710680 @default.
• W4386019076 cites W1995675594 @default.
• W4386019076 cites W2058188142 @default.
• W4386019076 cites W2068556430 @default.
• W4386019076 cites W2106084333 @default.
• W4386019076 cites W2134061682 @default.
• W4386019076 cites W2150529573 @default.
• W4386019076 cites W2259204994 @default.
• W4386019076 cites W2793046629 @default.
• W4386019076 cites W2892949113 @default.
• W4386019076 cites W3013447738 @default.
• W4386019076 cites W3048827006 @default.
• W4386019076 cites W3205063602 @default.
• W4386019076 cites W4207016957 @default.
• W4386019076 cites W4224290890 @default.
• W4386019076 cites W4231346141 @default.
• W4386019076 doi "https://doi.org/10.1080/1120009x.2023.2247200" @default.
• W4386019076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37599456" @default.
• W4386019076 hasPublicationYear "2023" @default.
• W4386019076 type Work @default.
• W4386019076 citedByCount "0" @default.
• W4386019076 crossrefType "journal-article" @default.
• W4386019076 hasAuthorship W4386019076A5004638853 @default.
• W4386019076 hasAuthorship W4386019076A5040931931 @default.
• W4386019076 hasAuthorship W4386019076A5057659279 @default.
• W4386019076 hasAuthorship W4386019076A5059618793 @default.
• W4386019076 hasAuthorship W4386019076A5086006586 @default.
• W4386019076 hasAuthorship W4386019076A5088738935 @default.
• W4386019076 hasConcept C104317684 @default.
• W4386019076 hasConcept C126322002 @default.
• W4386019076 hasConcept C127848430 @default.
• W4386019076 hasConcept C143998085 @default.
• W4386019076 hasConcept C150194340 @default.
• W4386019076 hasConcept C181199279 @default.
• W4386019076 hasConcept C190727270 @default.
• W4386019076 hasConcept C2776059313 @default.
• W4386019076 hasConcept C2776239401 @default.
• W4386019076 hasConcept C2777150147 @default.
• W4386019076 hasConcept C2777938653 @default.
• W4386019076 hasConcept C2778461978 @default.
• W4386019076 hasConcept C2778729363 @default.
• W4386019076 hasConcept C2779675984 @default.
• W4386019076 hasConcept C38652104 @default.
• W4386019076 hasConcept C41008148 @default.
• W4386019076 hasConcept C501734568 @default.
• W4386019076 hasConcept C54355233 @default.
• W4386019076 hasConcept C55493867 @default.
• W4386019076 hasConcept C71924100 @default.
• W4386019076 hasConcept C86803240 @default.
• W4386019076 hasConcept C9583187 @default.
• W4386019076 hasConceptScore W4386019076C104317684 @default.
• W4386019076 hasConceptScore W4386019076C126322002 @default.
• W4386019076 hasConceptScore W4386019076C127848430 @default.
• W4386019076 hasConceptScore W4386019076C143998085 @default.
• W4386019076 hasConceptScore W4386019076C150194340 @default.
• W4386019076 hasConceptScore W4386019076C181199279 @default.
• W4386019076 hasConceptScore W4386019076C190727270 @default.
• W4386019076 hasConceptScore W4386019076C2776059313 @default.
• W4386019076 hasConceptScore W4386019076C2776239401 @default.
• W4386019076 hasConceptScore W4386019076C2777150147 @default.
• W4386019076 hasConceptScore W4386019076C2777938653 @default.
• W4386019076 hasConceptScore W4386019076C2778461978 @default.
• W4386019076 hasConceptScore W4386019076C2778729363 @default.
• W4386019076 hasConceptScore W4386019076C2779675984 @default.
• W4386019076 hasConceptScore W4386019076C38652104 @default.
• W4386019076 hasConceptScore W4386019076C41008148 @default.
• W4386019076 hasConceptScore W4386019076C501734568 @default.
• W4386019076 hasConceptScore W4386019076C54355233 @default.
• W4386019076 hasConceptScore W4386019076C55493867 @default.
• W4386019076 hasConceptScore W4386019076C71924100 @default.
• W4386019076 hasConceptScore W4386019076C86803240 @default.
• W4386019076 hasConceptScore W4386019076C9583187 @default.
• W4386019076 hasLocation W43860190761 @default.
• W4386019076 hasLocation W43860190762 @default.
• W4386019076 hasOpenAccess W4386019076 @default.
• W4386019076 hasPrimaryLocation W43860190761 @default.
• W4386019076 hasRelatedWork W1906458404 @default.
• W4386019076 hasRelatedWork W1969013165 @default.
• W4386019076 hasRelatedWork W2069303197 @default.
• W4386019076 hasRelatedWork W2084945856 @default.
• W4386019076 hasRelatedWork W2119027399 @default.
• W4386019076 hasRelatedWork W2126817554 @default.
• W4386019076 hasRelatedWork W2128680685 @default.
• W4386019076 hasRelatedWork W3032643463 @default.
• W4386019076 hasRelatedWork W4307264101 @default.

• next